Mitochondria and GSK-3β in cardioprotection against ischemia/reperfusion injury

Cardiovascular Drugs and Therapy

Volumn 24, Issue 3, 2010, Pages 255-263

  Miura, Tetsuji ^a   Tanno, Masaya ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Glycogen synthase kinase 3 ; Mitochondria; Myocardial infarction; Reperfusion injury; Signal transduction

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE A2B RECEPTOR; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ION; CASPASE 3; CASPASE 8; CASPASE 9; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLOPHILIN D; GLYCOGEN SYNTHASE KINASE 3BETA; HEXOKINASE; HEXOKINASE ISOENZYME; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE C; PROTEIN P53; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL; CARDIOTONIC AGENT; CARRIER PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ANAEROBIC GLYCOLYSIS; APOPTOSIS; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DEATH; CELL PROTECTION; CELL SWELLING; COMORBIDITY; HEART CONTRACTION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYDROLYSIS; ISCHEMIC PRECONDITIONING; MITOCHONDRIAL INNER MEMBRANE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSMOLARITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SODIUM CALCIUM EXCHANGE; SODIUM TRANSPORT; ANIMAL; HEART INFARCTION; HEART INFARCTION PREVENTION; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION;

ANIMALS; CARDIOTONIC AGENTS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 78149361469     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-010-6234-z     Document Type: Review

References (110)

1. Kroemer G, Galuzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007;87:99-163. (Pubitemid 46209992)
2. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev. 1999;79:1127-55.
3. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004;116:205-19.
4. Murphy E, Steenbergen C. Preconditioning: the mitochondrial connection. Ann Rev Physiol. 2007;69:51-67.
5. Downey JM, Krieg T, Cohen MV. Mapping preconditioning's signaling pathways: an engineering approach. Ann N Y Acad Sci. 2008;1123:187-96.
6. Kostin S, Pool L, Elsässer A, Hein S, Drexler HC, Arnon E, et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res. 2003;92:715-24.
7. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007;446:444-8.
8. Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-9.
9. Peacock WF 4th, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008;358:2117-26.
10. Jennings RB, Reimer KA. The cell biology of acute myocardial ischemia. Annu Rev Med. 1991;42:225-46.
11. Opie LH, Sack MN. Metabolic plasticity and the promotion of cardiac protection in ischemia and ischemic preconditioning. J Mol Cell Cardiol. 2002;34:1077-89.
12. Di Lisa F, Menabò R, Canton M, Petronilli V. The role of mitochondria in the salvage and the injury of the ischemic myocardium. Biochim Biophys Acta. 1998;1366:69-78.
13. Piper HM, Abdallah Y, Schäfer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res. 2004;61:365-71.
14. +-ATPase activity during early reperfusion. Cardiovasc Res. 2006;70:364-73.
15. 2+], and NADH with dysfunction after global ischemia in intact hearts. Am J Physiol Heart Circ Physiol. 2001;280: H280-93.
16. Murphy E, Steenbergen C. Ion transport and energetics during cell death and protection. Physiology (Bethesda). 2008;23:115-23.
17. 2+ exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Cardiovasc Res. 2002;55:739-48.
18. Gunter TE, Pfeiffer DR. Mechanisms by which mitochondrial transport calcium. Am J Physiol. 1990;258: C755-86.
19. Jennings RB, Reimer KA, Steenbergen C. ischemia revisited. The osmotic load, membrane damage, and reperfusion. J Mol Cell Cardiol. 1986;18:769-80.
20. Flameng W, Andres J, Ferdinande P, Mattehussen M, Van Belle H. Mitochondrial function in myocardial stunning. J Mol Cell Cardiol. 1991;23:1-11.
21. Rouslin W. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol Heart Circ Physiol. 1983;244: H743-8.
22. Lesnefsky EJ, Tandler B, Ye J, Slabe TJ, Turkaly J, Hoppel CL. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol. 1997;273: H1544-54.
23. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol. 2001;33:1065-89.
24. Piper HM, Sezer O, Schleyer M, Schwartz P, Hutter JF, Spieckermann PG. Development of ischemia-induced damage in defined mitochondrial subpopulations. J Mol Cell Cardiol. 1985;17:885-96.
25. Noh H. Generation of superoxide radicals as byproduct of cellular respiration. Ann Biol Clin (Paris). 1994;52:199-204.
26. Lesnefsky EJ, Gudz DS, Migita CT, Ikeda-Saito M, Hassan MO, Turkaly PJ, et al. Ischemic injury to mitochondrial electron transport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys. 2001;385:117-28.
27. Becker LB, van den Hoek TL, Shao ZH, Li CQ, Schumacker PT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol Heart Circ Physiol. 1999;277: H2240-6.
28. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem. 2003;278:36027-31.
29. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552:335-44.
30. Iangovan G, Liebgott T, Kutala VK, Petryakov S, Zweier JL, Kuppusamy P. EPR oximetry in the beating heart: myocardial oxygen consumption rate as an index of postischemic recovery. Magn Reson Med. 2004;51:835-42.
31. Kevin LG, Camara AK, Riess ML, Novaliga E, Stowe DF. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2003;284: H566-74.
32. Merrill GF. Acetaminophen and low-flow myocardial ischemia: efficacy and antioxidant mechanisms. Am J Physiol Heart Circ Physiol. 2002;282: H1341-9.
33. Vanden Hoek TL, Li C, Shao Z, Schumacker PT, Becker LB. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol. 1997;29:2571-83.
34. Shih JC, Chen K, Ridd MJ. Monoamine oxidase: from genes to behavior. Ann Rev Neurosci. 1999;22:197-217.
35. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med. 2000;29:222-30.
36. Zhao ZQ, Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res. 2002;55:438-55.
37. Mani K. Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. Heart Fail Rev. 2008;13:193-209.
38. Gustafsson AB, Gottlieb RA. Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Heart Circ Physiol. 2007;292: C45-51.
39. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 1998;97:276-81.
40. Holly TA, Drincic A, Byun Y, Nakamura S, Harris K, Klocke FJ, et al. Caspase inhibition reduces myocyte death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol. 1999;31:1709-15.
41. Lee P, Sata M, Lefer DJ, Factor SM, Walsh K, Kitsis RN. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol. 2003;284: H456-63.
42. Ohno M, Takemura G, Ohno A, Misao J, Hayakawa Y, Minatoguchi S, et al. "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with In situ nick end-labeling. Circulation. 1998;98:1422-30.
43. Takemura G, Fujiwara H. Morphological aspects of apoptosis in heart diseases. J Cell Mol Med. 2006;10:56-75.
44. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285: H579-88.
45. Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res. 2006;70:308-14.
46. Kuno A, Critz SD, Cui L, Solodushko V, Yang XM, Krahn T, et al. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion. J Mol Cell Cardiol. 2007;43:262-71.
47. + exchanger for protection of the myocardium from lethal reperfusion injury. Cardiovasc Drugs Ther. 2002;16:295-301.
48. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res. 2002;55:534-43.
49. Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert D, et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol. 2005;38:367-74. (Pubitemid 40215206)
50. Schlack W, Uebing A, Schäfer M, Bier F, Schäfer S, Piper HM, et al. Regional contractile blockade at the onset of reperfusion reduces infarct size in the dog heart. Pflugers Arch. 1994;428:134-41.
51. Sebbag L, Verbinski SG, Reimer KA, Jennings RB. Protection of ischemic myocardium in dogs using intracoronary 2, 3-butanedione monoxime (BDM). J Mol Cell Cardiol. 2003;35:165-76.
52. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res. 2004;61:372-85.
53. Juhaszova M, Wang S, Zorov DB, Nuss HB, Gleichmann M, Mattson MP, et al. The identity and regulation of the mitochondrial permeability transition pore: where the known meets the unknown. Ann N Y Acad Sci. 2008;1123:197-212.
54. Di Lisa F, Bernardi P. A CaPful of mechanisms regulating the mitochondrial permeability transition. J Mol Cell Cardiol. 2009;46:775-80.
55. Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J. 1995;307:93-8.
56. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, et al. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest. 2004;113:1535-49.
57. Ruiz-Meana M, Pina P, Garcia-Dorado D, Rodríguez-Sinovas A, Barba I, Miró-Casas E, et al. Glycine protects cardiomyocytes against lethal reoxygenation injury by inhibiting mitochondrial permeability transition. J Physiol. 2004;558:873-82.
58. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature. 2004;427:461-5.
59. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol. 2007;9:550-5.
60. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. 2005;434:658-62.
61. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005;434:652-8.
62. Szewczyk A, Jarmuszkiewicz W, Kunz WS. Mitochondrial potassium channels. IUBMB Life. 2009;61:134-43.
63. ATP channels in preconditioning. J Mol Cell Cardiol. 2003;35:569-75.
64. Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD. cGMP signalling in pre-and post-conditioning: the role of mitochondria. Cardiovasc Res. 2008;77:344-52.
65. Andrukhiv A, Costa AD, West IC, Garlid KD. Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol. 2006;291: H2067-74.
66. + channel in cardiac function and cardioprotection. Biochim Biophys Acta. 2003;1606:1-21.
67. ATP opening on heart mitochondria. Am J Physiol Heart Circ Physiol. 2006;290: H406-15.
68. 2+ overload in rat cardiac mitochondria. J Physiol. 1999;519:347-60.
69. ATP channels attenuates the ouabaininduced calcium overload in mitochondria. Circ Res. 2001;89:856-8.
70. ATP channels in cell survival and death. J Mol Cell Cardiol. 2005;39:7-16.
71. Lim KH, Javadov SA, Das M, Clarke SJ, Suleiman MS, Halestrap AP. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol. 2002;545:961-74.
72. ATP channels in rat mitochondria. J Physiol. 2003;547:893-902.
73. Costa AD, Garlid KD. Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol. 2008;295: H874-82.
74. + channels in the cardiac inner mitochondrial membrane. Science 2002;298:1029-33.
75. Ca channels. Cardiovasc Res. 2008;77:398-405.
76. + channels via protein kinase A mediates desfluraneinduced preconditioning. Anesth Analg. 2008;106:384-91.
77. + channels in sildenafil-induced late cardiprotection. J Mol Cell Cardiol. 2008;44:105-13.
78. + channels is involved in ischemic preconditioning in canine hearts. J Mol Cell Cardiol. 2004;37:1213-8.
79. + influx increases respiration and enhances ROS production while maintaining membrane potential. Am J Physiol Cell Physiol. 2007;292: C148-56.
80. + channel opening requires superoxide radical generation. Am J Physiol Heart Circ Physiol. 2006;290: H434-40.
81. Jope RS, Yuskaitis CJ, Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res. 2007;32:577-95.
82. Sugden PH, Fuller SJ, Weiss SC, Clerk A. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol. 2008;153: S137-53.
83. Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3- kinase-dependent pathway is cardioprotective. Circ Res. 2002;90:377-9.
84. Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M. Inhibition of GSK3β by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation. 2008;117:2761-8.
85. Nishihara M, Miura T, Miki T, Sakamoto J, Tanno M, Kobayashi H, et al. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am J Physiol Heart Circ Physiol. 2006;291: H748-55.
86. Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res. 2004;94:960-6.
87. Obame FN, Plin-Mercier C, Assaly R, Zini R, Dubois-Randé JL, Berdeaux A, et al. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2, 4-dichlorophenyl)-4 (1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione], via inhibition of the mitochondrial permeability transition pore. J Pharmacol Exp Ther. 2008;326:252-8.
88. Wagner C, Kloeting I, Strasser RH, Weinbrenner C. Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. J Cardiovasc Pharmacol. 2008;52:430-7.
89. Kobayashi H, Miura T, Ishida H, Miki T, Tanno M, Yano T, et al. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion. Clin Exp Pharmacol Physiol. 2008;35:812-9.
90. Förster K, Paul I, Solenkova N, Staudt A, Cohen MV, Downey JM, et al. NECA at reperfusion limits infarction and inhibits formation of the mitochondrial permeability transition pore by activating p70S6 kinase. Basic Res Cardiol. 2006;101:319-26.
91. Park SS, Zhao H, Jang Y, Mueller RA, Xu Z. N6-(3-iodobenzyl) - adenosine-5′-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. J Pharmacol Exp Ther. 2006;318:124-31.
92. Nishihara M, Miura T, Miki T, Tanno M, Yano T, Naitoh K, et al. Modulation of the mitochondrial permeability transition pore complex in GSK-3β-mediated myocardial protection. J Mol Cell Cardiol. 2007;43:564-70.
93. Rodriguez-Sinovas A, Boengler K, Cabestrero A, Gres P, Morente M, Ruiz-Meana M, et al. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res. 2006;99:93-101.
94. Ohori K, Miura T, Tanno M, Miki T, Sato T, Ishikawa S, et al. Ser9 phosphorylation of mitochondrial GSK-3beta is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis. Am J Physiol Heart Circ Physiol. 2008;295: H2079-86.
95. Miki T, Miura T, Hotta H, Tanno M, Yano T, Sato T, et al. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3{beta}-mediated suppression of mitochondrial permeability transition. Diabetes 2009;58:2863-72.
96. Nishino Y, Webb IG, Davidson SM, Ahmed AI, Clark JE, Jacquet S, et al. Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res. 2008;103:307-14.
97. Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, et al. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res. 2009;104:15-8.
98. Pastorino JG, Hoek JB, Shulga N. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res. 2005;65:10545-54.
99. Miyamoto S, Murphy AN, Brown JH. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ. 2008;15:521-9.
100. Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004;29:95-102.
101. Watcharasit P, Bijur GN, Song L, Zhu J, Chen X, Jope RS. Glycogen synthase kinase-3β (GSK3β) binds to and promotes the actions of p53. J Biol Chem. 2003;278:48872-9.
102. Venkatapuram S, Wang C, Krolikowski JG, Weihrauch D, Kersten JR, Warltier DC, et al. Inhibition of apoptotic protein p53 lowers the threshold of isoflurane-induced cardioprotection during early reperfusion in rabbits. Anesth Analg. 2006;103:1400-5.
103. Das S, Wong R, Rajapakse N, Murphy E, Steenbergen C. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res. 2008;103:983-91.
104. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 2005;54:2360-4.
105. Itoh T, Miura T, Miki T, Yano T, Hotta H, Tanno M, et al. Distinct roles of ER stress and calcineurin in impaired protective signaling in the diabetic myocardium. [Abstract] Circ J. 2010;74:399-400.
106. Miki T, Miura T, Yano T, Takahashi A, Sakamoto J, Tanno M, et al. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling. J Pharmacol Exp Ther. 2006;317:68-75.
107. Miki T, Miura T, Tsuchida A, Nakano A, Hasegawa T, Fukuma T, et al. Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation. Circulation 2000;102:458-63.
108. Marcil M, Ascah A, Matas J, BeLanger S, Deschepper CF, Burelle Y. Compensated volume overload increases vulnerability of heart mitochondria without affecting their functions in the absence of stress. J Mol Cell Cardiol. 2006;41:998-1009.
109. Matas J, Young NT, Bourcier-Lucas C, Ascah A, Marcil M, Deschepper CF, et al. Increased expression and intramitochondrial translocation of cyclophilin-D associates with increased vulnerability of the permeability transition pore to stress-induced opening during compensated ventricular hypertrophy. J Mol Cell Cardiol. 2009;46:420-30.
110. Yano T, Miura T, Miki T, Tanno M, Kuno A, Itoh T, et al. ROS-mediated dysregulation of mitochondrial permeability transition pore underlies increase susceptibility of hypertensive hypertrophied hearts to ischemia/reperfusion injury. [Abstract] Circulation. 2009;120: S784.